zlacker

>>giulio+(OP)
Yet they seem to be spending more in restaurants:

> Ozempic Users Actually Spend More Dining Out.

> ..In casual dining establishments, they spend 25% more than non-GLP-1 households do, the market researcher says. Data firm Numerator shares similar findings, noting that while GLP-1 users report eating out less and cooking at home more, their spending says otherwise: “Verified purchase data reveals that their fast-food buy rate is up 2%.”

https://www.bloomberg.com/news/articles/2026-01-02/ozempic-g... (archive: https://archive.ph/V6Erv)

>>helsin+89
Maybe a bias on wealthier households in the US who can afford these drugs. Personally, my total food spending is down 30%. GLP 1 is $66CAD after insurance.

>>Chroma+Ce
I can't say exactly what the numbers are, but anecdotally, there are a lot of "research" users buying tirz (and reta, for that matter) for a few bucks a week on the gray market. The better known sources sell out batches in a week or two, which amounts to 750K-1M worth of product (at gray prices, not retail). There's a reason you're starting to see regular news stories about it.

I'm curious how these below-the-radar users skew the numbers. Maybe not at all?